These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 21482023

  • 1. Combination treatment using adenovirus vector-mediated tumor necrosis factor-alpha gene transfer and a NF-κB inhibitor for pancreatic cancer in mice.
    Furukawa K, Ohashi T, Haruki K, Fujiwara Y, Iida T, Shiba H, Uwagawa T, Kobayashi H, Yanaga K.
    Cancer Lett; 2011 Jul 01; 306(1):92-8. PubMed ID: 21482023
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of nuclear factor-κB enhances the antitumor effect of tumor necrosis factor-α gene therapy for hepatocellular carcinoma in mice.
    Haruki K, Shiba H, Fujiwara Y, Furukawa K, Iwase R, Uwagawa T, Misawa T, Ohashi T, Yanaga K.
    Surgery; 2013 Sep 01; 154(3):468-78. PubMed ID: 23972653
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of nuclear factor kappa-B enhances the antitumor effect of combination treatment with tumor necrosis factor-alpha gene therapy and gemcitabine for pancreatic cancer in mice.
    Fujiwara Y, Shiba H, Iwase R, Haruki K, Furukawa K, Uwagawa T, Misawa T, Ohashi T, Yanaga K.
    J Am Coll Surg; 2013 Feb 01; 216(2):320-32.e3. PubMed ID: 23219147
    [Abstract] [Full Text] [Related]

  • 4. Nafamostat mesilate can prevent adhesion, invasion and peritoneal dissemination of pancreatic cancer thorough nuclear factor kappa-B inhibition.
    Fujiwara Y, Furukawa K, Haruki K, Shimada Y, Iida T, Shiba H, Uwagawa T, Ohashi T, Yanaga K.
    J Hepatobiliary Pancreat Sci; 2011 Sep 01; 18(5):731-9. PubMed ID: 21484229
    [Abstract] [Full Text] [Related]

  • 5. Anti-tumor effect by inhibition of NF-kappaB activation using nafamostat mesilate for pancreatic cancer in a mouse model.
    Furukawa K, Iida T, Shiba H, Fujiwara Y, Uwagawa T, Shimada Y, Misawa T, Ohashi T, Yanaga K.
    Oncol Rep; 2010 Oct 01; 24(4):843-50. PubMed ID: 20811662
    [Abstract] [Full Text] [Related]

  • 6. Dual inhibition of nuclear factor kappa-B and Mdm2 enhance the antitumor effect of radiation therapy for pancreatic cancer.
    Shirai Y, Shiba H, Iwase R, Haruki K, Fujiwara Y, Furukawa K, Uwagawa T, Ohashi T, Yanaga K.
    Cancer Lett; 2016 Jan 28; 370(2):177-84. PubMed ID: 26546875
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death.
    Uwagawa T, Li Z, Chang Z, Xia Q, Peng B, Sclabas GM, Ishiyama S, Hung MC, Evans DB, Abbruzzese JL, Chiao PJ.
    Cancer; 2007 May 15; 109(10):2142-53. PubMed ID: 17410536
    [Abstract] [Full Text] [Related]

  • 8. Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation.
    Imre G, Gekeler V, Leja A, Beckers T, Boehm M.
    Cancer Res; 2006 May 15; 66(10):5409-18. PubMed ID: 16707469
    [Abstract] [Full Text] [Related]

  • 9. Potentiation of tumor necrosis factor-mediated apoptosis of oral squamous cell carcinoma cells by adenovirus-mediated gene transfer of NF-kappaB inhibitor.
    Chen S, Fribley A, Wang CY.
    J Dent Res; 2002 Feb 15; 81(2):98-102. PubMed ID: 11827262
    [Abstract] [Full Text] [Related]

  • 10. Combination paclitaxel and inhibitor of nuclear factor κB activation improves therapeutic outcome for model mice with peritoneal dissemination of pancreatic cancer.
    Fujiwara Y, Furukawa K, Shimada Y, Iida T, Shiba H, Uwagawa T, Misawa T, Ohashi T, Yanaga K.
    Pancreas; 2011 May 15; 40(4):600-7. PubMed ID: 21343836
    [Abstract] [Full Text] [Related]

  • 11. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
    Chen J, Ouyang ZG, Zhang SH, Zhen YS.
    Oncol Rep; 2007 Jun 15; 17(6):1445-51. PubMed ID: 17487403
    [Abstract] [Full Text] [Related]

  • 12. Gabexate mesilate, a synthetic anticoagulant, inhibits the expression of endothelial leukocyte adhesion molecules in vitro.
    Uchiba M, Okajima K, Kaun C, Binder BR, Wojta J.
    Crit Care Med; 2003 Apr 15; 31(4):1147-53. PubMed ID: 12682486
    [Abstract] [Full Text] [Related]

  • 13. NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis.
    Hatano E, Bennett BL, Manning AM, Qian T, Lemasters JJ, Brenner DA.
    Gastroenterology; 2001 Apr 15; 120(5):1251-62. PubMed ID: 11266388
    [Abstract] [Full Text] [Related]

  • 14. Combination chemotherapy of nafamostat mesilate with gemcitabine for pancreatic cancer targeting NF-kappaB activation.
    Uwagawa T, Chiao PJ, Gocho T, Hirohara S, Misawa T, Yanaga K.
    Anticancer Res; 2009 Aug 15; 29(8):3173-8. PubMed ID: 19661331
    [Abstract] [Full Text] [Related]

  • 15. Combination of tumor necrosis factor-alpha with sulindac augments its apoptotic potential and suppresses tumor growth of human carcinoma cells in nude mice.
    Yasui H, Adachi M, Imai K.
    Cancer; 2003 Mar 15; 97(6):1412-20. PubMed ID: 12627504
    [Abstract] [Full Text] [Related]

  • 16. Adenoviral gene transfer of ABIN-1 protects mice from TNF/galactosamine-induced acute liver failure and lethality.
    Wullaert A, Wielockx B, Van Huffel S, Bogaert V, De Geest B, Papeleu P, Schotte P, El Bakkouri K, Heyninck K, Libert C, Beyaert R.
    Hepatology; 2005 Aug 15; 42(2):381-9. PubMed ID: 16025521
    [Abstract] [Full Text] [Related]

  • 17. Combination chemotherapy of serine protease inhibitor nafamostat mesilate with oxaliplatin targeting NF-κB activation for pancreatic cancer.
    Gocho T, Uwagawa T, Furukawa K, Haruki K, Fujiwara Y, Iwase R, Misawa T, Ohashi T, Yanaga K.
    Cancer Lett; 2013 Jun 01; 333(1):89-95. PubMed ID: 23348695
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis.
    Lu YX, Ju HQ, Wang F, Chen LZ, Wu QN, Sheng H, Mo HY, Pan ZZ, Xie D, Kang TB, Chen G, Yun JP, Zeng ZL, Xu RH.
    Cancer Lett; 2016 Sep 28; 380(1):87-97. PubMed ID: 27322737
    [Abstract] [Full Text] [Related]

  • 19. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
    Matsumoto G, Namekawa J, Muta M, Nakamura T, Bando H, Tohyama K, Toi M, Umezawa K.
    Clin Cancer Res; 2005 Feb 01; 11(3):1287-93. PubMed ID: 15709200
    [Abstract] [Full Text] [Related]

  • 20. Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma.
    Chen CL, Wang SD, Zeng ZY, Lin KJ, Kao ST, Tani T, Yu CK, Wang JY.
    J Allergy Clin Immunol; 2006 Jul 01; 118(1):105-12. PubMed ID: 16815145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.